Google Übersetzer
Skye Bioscience, Inc.
About
0.73USD-0.05 -5.81%
Closed • Updated at 14:56 GMT+00:00Market Cap$25.74M
Volume36.8K
Beta5.04
RSI41.19
Skye Bioscience, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 12 2026
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 11 2026
Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
Apr 7 2026
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
Apr 2 2026
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
Mar 10 2026
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Recent Videos
Skye Bioscience Faces Lawsuit: What's Next? #SkyeBioscience #SKYE #Lawsuit #BiotechNews
Apr 13, 2026
Evolution of Obesity Management
Apr 01, 2026
The Detriment of Deranged Metabolism
Mar 24, 2026
The Metabolically Healthy Human
Mar 24, 2026